115 related articles for article (PubMed ID: 8813120)
21. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
22. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
Pedersen M; Rönnstrand L; Sun J
Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
[TBL] [Abstract][Full Text] [Related]
23. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
[TBL] [Abstract][Full Text] [Related]
24. Effects of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract.
Hirota S; Isozaki K; Nishida T; Kitamura Y
J Gastroenterol; 2000; 35 Suppl 12():75-9. PubMed ID: 10779223
[TBL] [Abstract][Full Text] [Related]
25. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
26. Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF-7.
Nishida K; Tsukamoto T; Uchida K; Takahashi T; Takahashi T; Ueda R
Anticancer Res; 1996; 16(6B):3397-402. PubMed ID: 9042197
[TBL] [Abstract][Full Text] [Related]
27. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
29. Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement.
Caruana G; Cambareri AC; Gonda TJ; Ashman LK
Oncogene; 1998 Jan; 16(2):179-90. PubMed ID: 9464535
[TBL] [Abstract][Full Text] [Related]
30. Developmental origin and Kit-dependent development of the interstitial cells of cajal in the mammalian small intestine.
Klüppel M; Huizinga JD; Malysz J; Bernstein A
Dev Dyn; 1998 Jan; 211(1):60-71. PubMed ID: 9438424
[TBL] [Abstract][Full Text] [Related]
31. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
Caruana G; Cambareri AC; Ashman LK
Oncogene; 1999 Sep; 18(40):5573-81. PubMed ID: 10523834
[TBL] [Abstract][Full Text] [Related]
32. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
[TBL] [Abstract][Full Text] [Related]
33. Kit ligand mediates survival of type A spermatogonia and dividing spermatocytes in postnatal mouse testes.
Packer AI; Besmer P; Bachvarova RF
Mol Reprod Dev; 1995 Nov; 42(3):303-10. PubMed ID: 8579844
[TBL] [Abstract][Full Text] [Related]
34. 'W' mutant forms of the Fms receptor tyrosine kinase act in a dominant manner to suppress CSF-1 dependent cellular transformation.
Reith AD; Ellis C; Maroc N; Pawson T; Bernstein A; Dubreuil P
Oncogene; 1993 Jan; 8(1):45-53. PubMed ID: 8380922
[TBL] [Abstract][Full Text] [Related]
35. Combination of KIT gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis.
Ruano I; Gargini R; Izquierdo M
Br J Haematol; 2010 Jan; 148(1):59-68. PubMed ID: 19804454
[TBL] [Abstract][Full Text] [Related]
36. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells.
Piao X; Bernstein A
Blood; 1996 Apr; 87(8):3117-23. PubMed ID: 8605325
[TBL] [Abstract][Full Text] [Related]
37. Decreased c-kit function inhibits enhanced skin carcinogenesis in c-Ha-ras protooncogene transgenic mice.
Muto S; Katsuki M; Horie S
Cancer Sci; 2007 Oct; 98(10):1549-56. PubMed ID: 17683512
[TBL] [Abstract][Full Text] [Related]
38. A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin.
Klimpel GR; Chopra AK; Langley KE; Wypych J; Annable CA; Kaiserlian D; Ernst PB; Peterson JW
J Exp Med; 1995 Dec; 182(6):1931-42. PubMed ID: 7500039
[TBL] [Abstract][Full Text] [Related]
39. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.
Kitayama H; Tsujimura T; Matsumura I; Oritani K; Ikeda H; Ishikawa J; Okabe M; Suzuki M; Yamamura K; Matsuzawa Y; Kitamura Y; Kanakura Y
Blood; 1996 Aug; 88(3):995-1004. PubMed ID: 8704259
[TBL] [Abstract][Full Text] [Related]
40. c-Kit and c-kit mutations in mastocytosis and other hematological diseases.
Boissan M; Feger F; Guillosson JJ; Arock M
J Leukoc Biol; 2000 Feb; 67(2):135-48. PubMed ID: 10670573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
